Trump Administration Cancels Meeting of FDA Vaccine Advisers, Risking Flu-Shot Delay
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...
US FDA issues warning letter to Granules India's Gagillapur facility
The development may temporarily delay the approval of pending product submissions from the site, but existing manufacturing ...
manilatimes39m
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...
MAP: Listeria strain in deadly outbreak found in these states as death toll climbs
A listeria outbreak tied to supplement shakes is now linked to at least 12 deaths and 38 cases across 21 states, according to ...
manilatimes1h
Dyne Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Research and development (R&D) expenses: R&D expenses were $81.8 million and $58.8 million for the quarters ended December 31, 2024 and 2023, respectively. R&D expenses were $281.4 million and $210.8 ...
pharmaphorum28m
Indivior changes CEO after warning sales will fall in 2025
The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...